HopeStage
Back to all studies
RecruitingNCT06336382

Blood and brain-imaging markers in late-onset psychosis

About this titleRead the official source — NCT06336382
Observational studyAges 65–85United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 65 years to 85 years.

Listed locations
ManhassetSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 16, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
16
Sponsor
Jeremy Koppel
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Diagnostic test
Locations
United States
Age range
From 65 Years to 85 Years
Official registry ID
NCT06336382
Official title
Show the full official title

Tau Biomarkers in Late-onset Psychosis (LOP)

Recruitment & locations

Currently recruiting

Manhasset

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Jeremy Koppel.

Who can participate?

Listed age limits: 65 years to 85 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies